Tissue expression and immunolocalization of tumor necrosis factor-α in postinfarction dysfunctional myocardium

Circulation

Volumn 99, Issue 11, 1999, Pages 1492-1498

  Irwin, Min W ^c   Mak, Susanna ^c   Mann, Douglas L ^a   Qu, Rong ^c   Penninger, Josef M ^c   Yan, Andrew ^c   Dawood, Fayez ^c   Wen, Wen Hu ^c   Shou, Zhiping ^c   Liu, Peter ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TORONTO GENERAL HOSPITAL   (Canada)

^c NONE

Author keywords

Cytokines; Heart failure; Infarction; Myocardium; Remodeling; Tissue; Tumor necrosis factor

Indexed keywords

MESSENGER RNA; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; GENE EXPRESSION; HEART INFARCTION; HEART MUSCLE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

EID: 0033596949     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.11.1492     Document Type: Article

References (37)

1. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236-241.
2. McMurray J, Abdullah I, Dargie H, Shapiro D. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J. 1991;66:356-358.
3. Tracey FJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol. 1993;9:317-343.
4. Beutler B, Cerami A. The biology of cachectin/TNF-α primary mediator of the host response. Ann Rev Immunol. 1989;7:625-655.
5. Torre-Amione G, Kapadia S, Lee J, Bies R, Lebovitz R, Mann D. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation. 1995;92:1487-1493.
6. Yokoyama T, Nakano M, Bednarczyk JL, McIntyre BW, Entman M, Mann DL. Tumor necrosis factor-α provokes a hypertrophic growth response in adult cardiac myocytes. Circulation. 1997;95:1247-1252.
7. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotyski CC, Quintana PJE, Sabadini RA. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest. 1996;98: 2854-2865.
8. Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol. 1995; 146:419-428.
9. Chandrasekar B, Freeman GL. Induction of nuclear factor κB and activation protein 1 in postischemic myocardium. FEBS Lett. 1997;401: 10-34.
10. Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, Mann DL. Hemodynamic regulation of tumor necrosis factor-α gene and protein expression in adult feline myocardium. Circ Res. 1997;81:187-195.
11. Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest. 1995;96: 1042-1052.
12. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest. 1993;92: 2303-2312.
13. Eichenholz PW, Eichacker PQ, Hoffman WD, Banks SM, Parrillo JE, Danner RL, Natanson C. Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. Am J Physiol. 1992;263: H668-H675.
14. Hegewisch S, Weh HJ, Hossfeld DK. TNF-induced cardiomyopathy. Lancet. 1990;2:294-295.
15. Horgan MJ, Palace GP, Everitt JE, Malik AB. TNF-α release in endotoxemia contributes to neutrophil-dependent pulmonary edema. Am J Physiol. 1993;264H1161-H1165.
16. Lo SK, Everitt J, Gu J, Malik AB. Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J Clin Invest. 1992;89:981-988.
17. Orenstein TL, Parker TG, Butany JW, Goodman JM, Dawood F, Wen WH, Wee L. Favorable left ventricular remodeling following large myocardial infarction by exercise training. J Clin Invest. 1995;96:858-866.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal Biochem. 1987;162:156-159.
19. Marx N, Neumann FJ, Ott I, Gawaz M, Koch W, Pinkau T, Schomig A. Induction of cytokine expression in leukocytes in acute myocardial infarction. J Am Coll Cardiol. 1997;30:165-170.
20. Chandrasekar B, Melby PC, Troyer DA, Freeman GL. Induction of proinflammatory cytokine expression in experimental acute chagasic cardiomyopathy. Biochem Biophys Res Commun. 1996;223:365-371.
21. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J. 1994;72:561-566.
22. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res. 1995;77:863-868.
23. Gottschall PE, Yu X. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem. 1995;64:1513-1520.
24. Gakus ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemon EN, Lark MW, Amento E, Libby P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res. 1994;75:181-189.
25. Fliss H, Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res. 1996;79:949-956.
26. Kajstura J, Chang W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest. 1996;74:86-107.
27. James TN. Normal and abnormal consequences of apoptosis in the human heart. Circulation. 1994;90:556-573.
28. Bennett MR, Schwartz SM. Apoptosis of rat vascular smooth muscle cells regulated by p53-dependent and -independent pathways. Circ Res. 1995; 77:266-273.
29. Tanaka M, Ito H, Adachi S, Akimoto H, Nishilkawa T, Kasajima T, Marumo F. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res. 1994;75:426-433.
30. Latini R, Bianchi M, Correale E, Dinarello CA, Fantuzzi G, Fresco C, Maggioni AP, Mengozzi M, Romano S, Shapiro L. Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist. J Cardiovasc Pharmacol. 1994;23:1-6.
31. Hirschl MM, Gwechenberger M, Binder T, Binder M, Graf S, Stefenelli T, Rauscha F, Laggner AN, Sochor H. Assessment of myocardial injury by serum tumour necrosis factor alpha measurements in acute myocardial infarction. Eur Heart J. 1996;17:1852-1859.
32. Basaran Y, Basaran MM, Babacan KF, Ener B, Okay T, Gok H, Ozdemir M. Serum tumor necrosis factor levels in acute myocardial infarction and unstable angina pectoris. Angiology. 1993;44:332-337.
33. 2+ transients. FEBS Lett. 1995;376:24-30.
34. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, Visioli O. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation. 1995;92:1479-1486.
35. Torre-Amione G, Kapadia S, Lee J, Durand J-B, Bies RD, Young JB, Mann DL. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704-711.
36. Porteu F, Nathan C. Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med. 1990;172:599-607.
37. Nakano M, Knowlton AA, Dibbs Z, Mann DL. Tumor necrosis factor-α confers resistance to hypoxic injury in the adult mammalian cardiac myocyte. Circulation. 1998;97:1392-1400.